Search results
Reeves says she hopes CEOs see their ‘fingerprints all over’ Labour manifesto
PA Media: Money via Yahoo Finance· 3 days agoMs Reeves told the summit that Labour had “campaigned as a pro-business party, and we will govern as...
ADA Scientific Sessions 2024 Go Beyond Glucose and Obesity
Medscape· 4 days agoThe American Diabetes Association (ADA) 84th Scientific Sessions, taking place June 21-24, 2024,...
Asthma Treatment During Pregnancy: Stay the Course!
Medscape· 3 days agoPregnancy is a period of asthma instability; it entails an increased risk for exacerbations. While therapeutic de-escalation, if not the outright...
XDefiant Boss Reacts To Progression Issues, Outlines Changes, And Admits He Screwed Up
GameSpot· 2 days agoUbisoft is making some changes.
Major drug companies cap asthma medication costs at $35 per month
WPBF West Palm Beach· 1 day agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks· 4 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face the FDA's partial clinical hold following the death of two patients.
How germ granules promote germ cell fate - Nature Reviews Genetics
Nature· 5 days agoIn this Review, Pamula and Lehmann describe how distinct membraneless germ granules organize the germ cell cytoplasm at different stages of the germline life cycle to determine germ cell identity ...
Anti-Israel student protests putting ‘handbrake’ on corporate diversity spending, says MindGym
The Telegraph via Yahoo Finance· 5 days agoAnti-Israel student protests on university campuses and Ron DeSantis’s so-called war on woke have...
Baird lifts Mirum Pharmaceuticals shares target on study results By Investing.com
Investing.com· 6 days agoOn Monday, Baird increased its price target on Mirum Pharmaceuticals (NASDAQ:MIRM) shares to $39...
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 3 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.